Scinai Immunotherapeutics Files 6-K Report

TL;DR

Scinai (SCIN) filed a 6-K for Q2 2025, former BiondVax.

AI Summary

Scinai Immunotherapeutics Ltd. filed a Form 6-K on September 2, 2025, reporting information for the period ending June 30, 2025. The filing includes a press release from the company. Scinai Immunotherapeutics was formerly known as BiondVax Pharmaceuticals Ltd. until a name change on June 24, 2014.

Why It Matters

This filing provides an update on Scinai Immunotherapeutics' activities and financial reporting for the period ending June 30, 2025, which is important for investors to assess the company's current status.

Risk Assessment

Risk Level: low — This is a routine filing (6-K) that primarily serves as a report of foreign private issuer information and does not contain significant new financial or strategic disclosures.

Key Players & Entities

• Scinai Immunotherapeutics Ltd. (company) — Filer
• BiondVax Pharmaceuticals Ltd. (company) — Former company name
• June 30, 2025 (date) — Period of report
• September 2, 2025 (date) — Filing date
• June 24, 2014 (date) — Date of name change

FAQ

From the Filing

0001213900-25-083373.txt : 20250902 0001213900-25-083373.hdr.sgml : 20250902 20250902161610 ACCESSION NUMBER: 0001213900-25-083373 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 54 CONFORMED PERIOD OF REPORT: 20250630 FILED AS OF DATE: 20250902 DATE AS OF CHANGE: 20250902 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Scinai Immunotherapeutics Ltd. CENTRAL INDEX KEY: 0001611747 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37353 FILM NUMBER: 251285682 BUSINESS ADDRESS: STREET 1: JERUSALEM BIOPARK, 2ND FLOOR STREET 2: HADASSAH EIN KEREM CAMPUS CITY: JERUSALEM STATE: L3 ZIP: 00000 BUSINESS PHONE: 972-8-9302529 MAIL ADDRESS: STREET 1: JERUSALEM BIOPARK, 2ND FLOOR STREET 2: HADASSAH EIN KEREM CAMPUS CITY: JERUSALEM STATE: L3 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: BiondVax Pharmaceuticals Ltd. DATE OF NAME CHANGE: 20140624 6-K 1 ea0255452-6k_scinai.htm REPORT OF FOREIGN PRIVATE ISSUER     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 6-K   Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934   For the Month of September 2025   Commission File Number: 001-37353          SCINAI IMMUNOTHERAPEUTICS LTD. (Translation of registrant’s name into English)   Jerusalem BioPark, 2nd Floor Hadassah Ein Kerem Campus Jerusalem, Israel (Address of principal executive office)   Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.   Form 20-F ☒       Form 40-F ☐             EXPLANATORY NOTE     Attached are the Company’s press release providing a business update for the first half of 2025, condensed interim unaudited financial statements and a summary of its operating and financial review and prospects, each as of June 30, 2025, furnished herewith as Exhibits 99.1, 99.2 and 99.3, respectively   This Report on Form 6-K (including Exhibits 99.1, 99.2 and 99.3) is hereby incorporated by reference into the registrant’s Registration Statements on Form S-8 (File No.  333-271293  and File No.  333-239344 ) and Form F-3 (File No.  333-274078  and File No.  333-276767 ), to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.   Exhibit Index   Exhibit No.   Description 99.1   Press Release dated September 2, 2025 99.2   Condensed Consolidated Unaudited Financial Statements as of June 30, 2025 99.3   Operating and Financial Review and Prospects as of June 30, 2025 101.INS   Inline XBRL Instance Document 101.SCH   Inline XBRL Taxonomy Extension Schema Document 101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF   Inline XBRL Taxonomy Extension Label Linkbase Document 101.LAB   Inline XBRL Taxonomy Extension Presentation Linkbase Document 101.PRE   Inline XBRL Taxonomy Extension Definition Linkbase Document 104   Cover Page Interactive Data File formatted as Inline XBRL and contained in Exhibit 101   1     SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.     Scinai Immunotherapeutics Ltd.       Date: September 2, 2025 By: /s/ Amir Reichman     Amir Reichman     Chief Executive Officer   2   EX-99.1 2 ea025545201ex99-1_scinai.htm PRESS RELEASE